ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 2 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,175,110 | -12.1% | 1,303,988 | +1.0% | 1.64% | -2.2% |
Q2 2023 | $30,921,701 | +36.1% | 1,291,094 | +6.9% | 1.68% | +25.0% |
Q1 2023 | $22,721,424 | +36.1% | 1,207,302 | +15.1% | 1.34% | +29.8% |
Q4 2022 | $16,696,100 | -1.2% | 1,048,750 | +1.6% | 1.03% | -3.2% |
Q3 2022 | $16,896,000 | +56.3% | 1,032,739 | +34.7% | 1.07% | +70.6% |
Q2 2022 | $10,807,000 | -31.4% | 766,971 | +18.0% | 0.63% | -10.1% |
Q1 2022 | $15,743,000 | -4.7% | 649,993 | -8.2% | 0.70% | +19.6% |
Q4 2021 | $16,524,000 | – | 707,969 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |